Increased gene expression of BMP2 has been reported in human osteoblasts treated with cadmium and in patients with non-alcoholic fatty liver disease (NAFLD) [61,62]. This evidence concerns the gene BMP2 and metabolic dysfunction-associated steatotic liver disease.